News & HighlightsNews
Jeffrey Ravetch wins Wolf Prize in Medicine
Jeffrey V. Ravetch, head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology at Rockefeller University, was named a recipient of the 2015 Wolf Prize in Medicine on Friday (January 30) and will receive the award at a ceremony in Tel Aviv in May. He shares the prize, which include...
In the News - GlobeAndMail - Nussenzweig
HIV: Latent reservoir of virus in rare immune cells could help develop cure "Research at Rockefeller University suggests that a quiet body of immune cells that do not divide could harbour a reserve of HIV virus, a potential target for therapies aimed at curing rather than managing the disease."
Latent HIV may lurk in ‘quiet’ immune cells, research suggests
Drugs for HIV have become adept at suppressing infection, but they still can’t eliminate it. That’s because the medication in these pills doesn’t touch the virus’ hidden reserves, which lie dormant within infected white blood cells. Unlock the secrets of this pool of latent virus, scientists...
In the News - Huffington Post - Kreek
Dying to be free: The treatment for heroin addiction we aren’t using   “[Opiate addiction] 'alters multiple regions in the brain,' [Mary Jeanne] Kreek said, 'including those that regulate reward, memory and learning, stress responsivity, and hormonal response, as well as executive function whic...
Research implicates metabolic process of the liver in the spread of colorectal cancer
Colorectal cancer is a cancer on the move: about 50 percent of patients with the disease see their cancer spread, typically to the liver. By identifying genes that become activated in cancer cells that successfully travel — metastasize — to the liver, researchers at Rockefeller have implicated...
Study detailing axonal death pathway may provide drug targets for neurodegenerative diseases
Axons connect neurons with each other to form the neural networks that underpin the vital functions of perception, motility, cognition, and memory. In many neurodegenerative disorders, from traumatic injury or toxic damage to diseases such as Alzheimer’s or Parkinson’s disease, axonal degenerati...
In the News - BBC News - Brady
Drugs in dirt: Scientists appeal for help "Dr. [Sean] Brady, head of the Laboratory of Genetically Encoded Small Molecules, said: 'We hope that efforts to map nature's microbial and chemical diversity will result in the discovery of both completely new medicines and better versions of existing me...
Cancer biologist and physician Sohail Tavazoie is promoted to associate professor
Sohail Tavazoie, head of the Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology, has been promoted to associate professor, effective January 1. Tavazoie, who joined Rockefeller in 2009, works to understand how cancer cells become able to escape a tumor and invade other organs, a pro...
Long-acting drug effectively prevents HIV-like infection in monkeys
A regime of anti-HIV drugs — components of regimens to treat established HIV infection — has the potential to protect against infection in the first place. But real life can interfere; the effectiveness of this prophylactic approach declines if the medications aren’t taken as prescribed. ...
Physician scientist, interested in obesity-related disease, to join faculty
More than one in three U.S. adults is obese, a condition that puts them at risk for an alarming array of health problems, from diabetes and heart disease to cancer. But while obesity brings devastating consequences for many, some escape. For a select few, obesity causes little more than sore join...
View
View